All of these encourage us that, cancer cells may develop anti-PTMs of STING strategy to avoid surveillance of host immune system, and targeted PTMs of STING could be potential therapy for cancer, especially those STING-sensitive cancers (Table 1). Here, STING1 is linked to cancer.